ZA902168B - Novel benzothiopyranylamines - Google Patents

Novel benzothiopyranylamines

Info

Publication number
ZA902168B
ZA902168B ZA902168A ZA902168A ZA902168B ZA 902168 B ZA902168 B ZA 902168B ZA 902168 A ZA902168 A ZA 902168A ZA 902168 A ZA902168 A ZA 902168A ZA 902168 B ZA902168 B ZA 902168B
Authority
ZA
South Africa
Prior art keywords
und
dieser verbindungen
benzothiopyranylamines
novel
die
Prior art date
Application number
ZA902168A
Other languages
English (en)
Inventor
Alan J Hutchison
J Hutchison Alan
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of ZA902168B publication Critical patent/ZA902168B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Cosmetics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Tea And Coffee (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA902168A 1989-03-22 1990-03-21 Novel benzothiopyranylamines ZA902168B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32694989A 1989-03-22 1989-03-22

Publications (1)

Publication Number Publication Date
ZA902168B true ZA902168B (en) 1990-11-28

Family

ID=23274473

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA902168A ZA902168B (en) 1989-03-22 1990-03-21 Novel benzothiopyranylamines

Country Status (22)

Country Link
US (1) US5071858A (is")
EP (1) EP0389425B1 (is")
JP (1) JPH06102657B2 (is")
KR (1) KR900014357A (is")
AT (1) ATE121740T1 (is")
AU (1) AU632318B2 (is")
CA (1) CA2012569A1 (is")
DD (1) DD292913A5 (is")
DE (1) DE69018864D1 (is")
DK (1) DK0389425T3 (is")
ES (1) ES2071074T3 (is")
FI (1) FI94863C (is")
GR (1) GR3015938T3 (is")
HU (1) HU206205B (is")
IE (1) IE67871B1 (is")
IL (2) IL93814A0 (is")
MX (1) MX19953A (is")
NO (1) NO174669C (is")
NZ (1) NZ233002A (is")
PT (1) PT93515B (is")
TW (1) TW204347B (is")
ZA (1) ZA902168B (is")

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06500099A (ja) * 1990-08-13 1994-01-06 ジー.ディー.サール アンド カンパニー Cns疾病の処置におけるヘテロ環状アミノ―アルコール化合物の使用
FR2691149B1 (fr) * 1992-05-18 1994-07-08 Adir Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5428307A (en) * 1993-10-20 1995-06-27 Silicon Systems, Inc. Closed-loop peak detector topology
JPH0967367A (ja) * 1995-06-23 1997-03-11 Suntory Ltd チオピラン誘導体
FR2739855B1 (fr) * 1995-10-13 1997-11-14 Adir Nouvelles amines heterocycliques tertiaires, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2763335B1 (fr) * 1997-05-16 2000-11-24 Adir Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20050148018A1 (en) * 1999-10-07 2005-07-07 David Weiner Methods of identifying inverse agonists of the serotonin 2A receptor

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2077733B1 (is") * 1970-02-10 1973-03-16 Roussel Uclaf
GB1407552A (en) * 1973-04-02 1975-09-24 Science Union & Cie Disubstituted piperazines processes for their preparation and pharmaceutical compositions containing them
US4039676A (en) * 1975-06-23 1977-08-02 Ciba-Geigy Corporation 2-piperidinoalkyl-1,4-benzodioxans
US4468404A (en) * 1980-12-12 1984-08-28 Schering Corporation 3-Aralkyloxy-2,3-dihydro-2-(triazolymethyl)benzo(b)thiophenes
FI79535C (fi) * 1982-05-06 1990-01-10 Erba Farmitalia Foerfarande foer framstaellning av dihydrobensopyrans och dihydrobensotiopyrans substituerade iminoderivat.
GB8515389D0 (en) * 1985-06-18 1985-07-17 Ici Plc Heterocyclic compounds
DE3771280D1 (de) * 1986-06-26 1991-08-14 Ciba Geigy Ag Hydrierte 1-benzooxacycloalkyl-pyridincarbonsaeureverbindungen.
US4801605A (en) * 1986-08-29 1989-01-31 Ciba-Geigy Corporation 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans
GB8704572D0 (en) * 1987-02-26 1987-04-01 Lundbeck & Co As H Organic compounds
ES2059828T3 (es) * 1988-01-15 1994-11-16 Abbott Lab Un procedimiento para la preparacion de un compuesto.
CA2048846A1 (en) * 1990-08-15 1992-02-16 Craig Steven Hoechstetter Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes, 3-aminochromanes, and aminothiochromanes

Also Published As

Publication number Publication date
IL93814A0 (en) 1990-12-23
DK0389425T3 (da) 1995-05-22
IL93814A (en) 1995-07-31
NO174669C (no) 1994-06-15
TW204347B (is") 1993-04-21
JPH037280A (ja) 1991-01-14
NO901303D0 (no) 1990-03-21
MX19953A (es) 1994-01-31
PT93515B (pt) 1996-08-30
KR900014357A (ko) 1990-10-23
IE67871B1 (en) 1996-05-01
AU5208690A (en) 1990-11-08
EP0389425B1 (de) 1995-04-26
PT93515A (pt) 1990-11-07
CA2012569A1 (en) 1990-09-22
DD292913A5 (de) 1991-08-14
DE69018864D1 (de) 1995-06-01
FI901371A0 (fi) 1990-03-19
US5071858A (en) 1991-12-10
IE901036L (en) 1990-09-22
FI94863C (fi) 1995-11-10
ATE121740T1 (de) 1995-05-15
AU632318B2 (en) 1992-12-24
GR3015938T3 (en) 1995-07-31
HUT53632A (en) 1990-11-28
NO901303L (no) 1990-09-24
HU901636D0 (en) 1990-11-28
NO174669B (no) 1994-03-07
JPH06102657B2 (ja) 1994-12-14
EP0389425A1 (de) 1990-09-26
HU206205B (en) 1992-09-28
NZ233002A (en) 1992-07-28
FI94863B (fi) 1995-07-31
ES2071074T3 (es) 1995-06-16

Similar Documents

Publication Publication Date Title
DE69006472D1 (en) Zahnärztliche Zusammensetzungen, Verfahren zur Herstellung von geformten, zahnärztlichen Artikeln via "photoiniferte Polymerisation" von zahnärztlichen Zusammensetzungen und dadurch erzeugte geformte, zahnärztliche Artikel.
ATE126433T1 (de) Verwendung von gamma-hydroxy-buttersäuresalzen zur herstellung von pharmazeutischen zusammensetzungen zur verwendung bei der behandlung von alkoholismus und die hergestellten zusammensetzungen.
ATE79264T1 (de) Verwendung von bismuth zur herstellung von medikamenten zur behandlung von magendarmst¯rungen, die von campylobacter polyridis verursacht sind.
DE3887625D1 (de) Verfahren zur Herstellung von 1,1,1-Trifluorodichlorethan und von 1,1,1,2-Tetrafluorchlorethan.
DE59100830D1 (de) Verfahren zur Herstellung von 3-Aminomethyl-3,5,5,-trimethyl-cyclohexylamin.
DE69008456D1 (de) Filmzusammensetzung zur Behandlung von Oberflächen und Verfahren zu ihrer Herstellung.
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
DE3882775D1 (de) Zusammensetzung zur behandlung von parodontaler krankheit.
DE59007399D1 (de) Verfahren zur herstellung von 1,4-bis-(4-hydroxybenzoyl)-benzol.
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
DE69011985D1 (de) Medizinisches Material, Verfahren zu seiner Herstellung und medizinisches Gerät, in dem dieses Material verwendet wird.
ZA902168B (en) Novel benzothiopyranylamines
DE69427955D1 (de) Verfahren zur Herstellung von 2,2-Difluorketensilylacetalen und alpha,alpha-Difluor-beta -Silyloxy-1,3-Dioxolan-4-Propansäureestern
DE3787543D1 (de) Verfahren zur herstellung von 6,13-dihydrochinacridonen und chinacridonen.
DE59003390D1 (de) Verfahren zur Herstellung von Butandiol-1,4 und Tetrahydrofuran.
PT69999A (de) 1,2,3-triazolcarbonsaureamide verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
ATE113598T1 (de) Substituierte vinylcephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE69002134D1 (de) Verfahren zur herstellung von 1,1-dichlor-1-fluoroethan und 1-chlor-1-1-difluorethan.
DE59007162D1 (de) Verfahren zur herstellung von 1,4-bis-(4-hydroxybenzoyl)-benzol.
DE69326050D1 (de) Verfahren zur Herstellung von 0,0'-Diacylweinsäureanhydrid und Verfahren zur Herstellung von 0,0'-Diacylweinsäure
ATE166385T1 (de) Vorrichtung für eine entalkoholisierungsanlage
PT76582A (de) 1,2,4-triazol-1-yl-propionitrile verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
HU908017D0 (en) Process for the preparation of naphloxazines and medical preparation made of them
DE69004244D1 (de) Verfahren zur Herstellung von hohen Anteilen des trans,trans-Isomeren enthaltenden 4,4'-Diisocyanatodicyclohexylmethan.
DE3886101D1 (de) 14-Chlorodaunomycin und Verfahren zur Herstellung von 14-Chlorodaunomycin und Verfahren zur Herstellung von (2"R)-4'-O-Tetrahydropyramyladriamycin.